Home / World Marketplace / Archive by category Global Health & Biotech (Page 19)

Archive by category Global Health & Biotech

Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin

Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studies DURHAM, N.C., June 24, 2025 (Korea Bizwire) – Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced a strategic collaboration with Emery Pharma, a leading analytical and bioanalytical CRO providing testing services under current [...]

Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will report to Chief Executive Officer Deepak Nath and join the Smith+Nephew Executive Committee. As both a senior management consultant and investment banker, Ajay has advised CEOs and Boards at [...]

EveLab Insight Debuts Dynamic Wrinkle Detection Technology at VivaTech 2025, Shaping the Future of AI-Powered Skin Wellness

SINGAPORE, June 23, 2025 (Korea Bizwire) — EveLab Insight, a global leader in AI skin analysis technology, successfully concluded its debut at VivaTech 2025, Europe’s premier innovation and technology event. From June 11-14, the company showcased a major advancement in visual AI: real-time dynamic wrinkle analysis, which brings a new dimension to personalized early-ageing awareness [...]

Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a strategic partnership with Standard Health www.standardhealth.co.uk to support the development of the first-ever Orthopaedic Ambulatory Surgery Centre in the UK. Based in Poole, Dorset, the new centre will offer NHS and private patients access to leading joint repair and replacement technology for conditions such as rotator [...]

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun Pharma-Teva collaboration agreement established with goal of accelerating clinical data generation for TEV-56278 Partnership leverages strategic relationships to enable research and development of innovative treatments to advance Teva’s Pivot to Growth strategy TEL AVIV, [...]

Global Fatty Liver Day 2025: Elevating Liver Health in the Metabolic Health Conversation

Global Liver Institute Calls for Urgent Action as Fatty Liver Disease Prevalence Surges Worldwide Washington, D.C., June 11, 2025 (Korea Bizwire) – On the second Thursday in June, Global Fatty Liver Day (formerly International NASH Day) spotlights one of the most widespread yet under-addressed health threats of our time: fatty liver disease, increasingly referred to as steatotic [...]

Spring Bio Solution Launches NCE Grid to decode Para IV Filing and First-to-File Opportunities

SOMERSET, N.J., June 11, 2025 (Korea Bizwire) — Spring Bio Solution, a global leader in the comparator sourcing and clinical trial supplies, has launched NCE Grid, the world’s first free NCE-1 intelligence platform - built to decode, centralize, and visualize Para IV and NCE-1 opportunities in real-time. Until now, tracking NCE exclusivity expirations and Paragraph IV filings has been a fragmented, [...]

Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs

A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to life-extending cardiac care for dogs Ingelheim, Germany, and San Francisco, Calif., June 10, 2025 | Boehringer Ingelheim, a global leader in animal health, and Eko Health, a pioneer in applying artificial intelligence (AI) for early detection of [...]

AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer’s Disease

Seongnam-si, South Korea and Abu Dhabi, UAE, June 09, 2025 (Korea Bizwire) – AriBio Co., Ltd. (“AriBio”), a South Korean biopharmaceutical company specializing in neurodegenerative diseases, and a Swiss pharmaceutical company Acino, part of Arcera, a global life sciences company based in Abu Dhabi (collectively “Arcera”), today announced the signing of exclusive licensing and commercialization, [...]

New medial stabilized insert for Smith+Nephew’s LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a steep rise in popularity, growing from 4% of Total Knee Arthroplasty procedures in 2018 to 32% in 2023.1 With the ability to be used [...]